Fibrolamellar Carcinoma
📧 Sign up to get email alerts when something new happens for Fibrolamellar Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial update of sapanisertib with ziv-aflibercept in patients with recurrent, metastatic, or unresectable solid tumors, including fi…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A Phase 1/2 trial of KAT-101 for hepatocellular carcinoma and fibrolamellar carcinoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Phase 2]
Phase 2 trial updates on Everolimus with or without estrogen deprivation therapy in unresectable fibrolamellar hepatocellular carcinoma; res…